Abstract Aberrant N 6-methyladenosine (m6A) modification has emerged as a driver of
tumor initiation and progression, yet how long noncoding RNAs (lncRNA) are involved in the …

Abstract m 6 A methylation is the most frequent modification of mRNA in eukaryotes and
plays a crucial role in cancer progression by regulating biological functions. Insulin-like …

Abstract Purpose of Review Patients with localized renal cell carcinoma (RCC) are at risk of
recurrence. The purpose of this review was to characterize the literature on recurrence rates …

Insulin‐like growth factor‐2 messenger RNA‐binding protein 3 (IGF2BP3) has been
reported to contribute to tumorigenesis in several human cancers. However, the biological …

Background Renal cell carcinoma (RCC) is a deadly urological tumor that remains largely
incurable. Our limited understanding of key molecular mechanisms underlying RCC …

Because of the lack of sensitivity to radiotherapy and chemotherapy, therapeutic options for
renal clear cell carcinoma (KIRC) are scarce. Long noncoding RNAs (lncRNAs) play crucial …

Renal cell carcinoma is the most common form of the kidney cancer accounting for more
than 85% of the cases of which clear cell renal cell carcinoma (ccRCC) is the major …

Renal cell carcinoma (RCC) is not sensitive to conventional radio-and chemotherapies and
is at least partially resistant to impairments in cell death-related signaling pathways. The …

Insulin-like growth factor II mRNA-binding protein 3 (IGF2BP3) has been proved to affect
trophoblast function and embryonic development, but its role and potential mechanism in …

Background The prognosis for patients with hepatocellular carcinoma (HCC) is poor, and
the mechanisms underlying the development of HCC remain unclear. Notch1 and Notch3 …